Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9626
CALL
Chesapeake Utilities
CPK
$3.26B
| $268K | ﹤0.01% |
2,500
-300
| -11% | -$31K |
|
|
NVNO
9627
CALL
enVVeno Medical
NVNO
$7.5M
| $268K | ﹤0.01% |
1,409
+780
| +124% | +$140K |
|
9628
PUT
Cedar Fair
FUN
$1.68B
| $268K | ﹤0.01% |
6,400
+1,300
| +25% | +$53K |
|
9629
PUT
Core Laboratories
CLB
$571M
| $268K | ﹤0.01% |
15,700
-7,000
| -31% | -$110K |
|
9630
CALL
Edgewise Therapeutics
EWTX
$4.8B
| $268K | ﹤0.01% |
14,700
+10,100
| +220% | +$161K |
|
9631
Opko Health
OPK
$1.03B
| $268K | ﹤0.01% |
223,386
-185,165
| -45% | -$185K |
|
9632
PUT
PetMed Express
PETS
$39.6M
| $268K | ﹤0.01% |
55,900
+10,700
| +24% | +$62.2K |
|
9633
Stantec
STN
$8.28B
| $268K | ﹤0.01% |
3,222
-37,916
| -92% | -$3.12M |
|
|
BLUE
9634
DELISTED
bluebird bio
BLUE
| $267K | ﹤0.01% |
10,447
-63,745
| -86% | -$1.63M |
|
9635
PUT
Ispire Technology
ISPR
$89M
| $267K | ﹤0.01% |
43,600
+34,100
| +359% | +$343K |
|
9636
CALL
Unitil
UTL
$995M
| $267K | ﹤0.01% |
+5,100
| New | +$257K |
|
9637
PUT
Kirby Corp
KEX
$7.32B
| $267K | ﹤0.01% |
2,800
-1,600
| -36% | -$135K |
|
9638
ProShares Global Listed Private Equity ETF
PEX
$11.6M
| $267K | ﹤0.01% |
9,036
-2,916
| -24% | -$83.2K |
|
9639
Bionano Genomics
BNGO
$13.9M
| $267K | ﹤0.01% |
4,004
+634
| +19% | +$47.3K |
|
9640
PUT
NETGEAR
NTGR
$656M
| $267K | ﹤0.01% |
16,900
-17,000
| -50% | -$247K |
|
9641
PUT
Ryan Specialty Holdings
RYAN
$10.7B
| $266K | ﹤0.01% |
4,800
-3,000
| -38% | -$143K |
|
9642
Quetta Acquisition Corp Unit
QETAU
| $266K | ﹤0.01% |
25,913
-9,084
| -26% | -$93.3K |
|
|
AMNB
9643
DELISTED
American National Bankshares Inc
AMNB
| $266K | ﹤0.01% |
+5,573
| New | +$257K |
|
9644
Townsquare Media
TSQ
$104M
| $266K | ﹤0.01% |
+24,234
| New | +$259K |
|
9645
Invesco Biotechnology & Genome ETF
PBE
$378M
| $266K | ﹤0.01% |
+4,111
| New | +$268K |
|
9646
Crescent Capital BDC
CCAP
$411M
| $266K | ﹤0.01% |
15,410
-68,558
| -82% | -$1.15M |
|
9647
PUT
Gates Industrial Corp
GTES
$7.03B
| $266K | ﹤0.01% |
15,000
+14,000
| +1,400% | +$203K |
|
9648
PUT
TaskUs
TASK
$688M
| $266K | ﹤0.01% |
22,800
+4,100
| +22% | +$51.2K |
|
9649
Atlas Lithium Corp
ATLX
$94.7M
| $266K | ﹤0.01% |
15,604
+9,249
| +146% | +$184K |
|
9650
PUT
Navigator Holdings
NVGS
$1.29B
| $266K | ﹤0.01% |
17,300
+9,900
| +134% | +$153K |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,748 new positions and closed 1,439 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.